Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Bibliographic Details
Main Author:	Mirza, Maisa Tasnim
Other Authors:	Jamiruddin, Dr. Mohd. Raeed
Format:	Thesis
Language:	English
Published:	Brac University 2023
Subjects:	Aromatase inhibitors Breast cancer Ductal carcinoma in situ Estrogen receptor positive Hormonal therapy Tamoxifen. Breast > Cancer > Chemoprevention.
Online Access:	http://hdl.handle.net/10361/18147

id	10361-18147
record_format	dspace
spelling	10361-181472023-04-13T21:01:43Z Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ Mirza, Maisa Tasnim Jamiruddin, Dr. Mohd. Raeed Department of Pharmacy, Brac University Aromatase inhibitors Breast cancer Ductal carcinoma in situ Estrogen receptor positive Hormonal therapy Tamoxifen. Tamoxifen. Breast--Cancer--Chemoprevention. This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022. Cataloged from PDF version of thesis. Includes bibliographical references (pages 22-25). The most common cause of cancer among women is breast cancer, accounting for almost one in every ten new cases of cancer every year. Invasive lesions include ductal carcinoma (now called 'no special type' (NST)) as well as lobular carcinoma, both of which have preinvasive counterparts in the form of ductal carcinoma in situ along with lobular cancer in situ (or lobular neoplasia). DCIS normally has no outward signs or symptoms. Yet, a lump or discharge from the nipple might be observed in a few cases. Many classification systems have been created due to the microscopic heterogeneity of DCIS. This review was conducted to find out whether Tamoxifen is the ideal choice of therapy for post operative DCIS among other therapies. Maisa Tasnim Mirza B. Pharmacy 2023-04-13T07:38:04Z 2023-04-13T07:38:04Z 2022 2022-08 Thesis ID: 18146017 http://hdl.handle.net/10361/18147 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 25 pages application/pdf Brac University
institution	Brac University
collection	Institutional Repository
language	English
topic	Aromatase inhibitors Breast cancer Ductal carcinoma in situ Estrogen receptor positive Hormonal therapy Tamoxifen. Tamoxifen. Breast--Cancer--Chemoprevention.
spellingShingle	Aromatase inhibitors Breast cancer Ductal carcinoma in situ Estrogen receptor positive Hormonal therapy Tamoxifen. Tamoxifen. Breast--Cancer--Chemoprevention. Mirza, Maisa Tasnim Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
description	This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
author2	Jamiruddin, Dr. Mohd. Raeed
author_facet	Jamiruddin, Dr. Mohd. Raeed Mirza, Maisa Tasnim
format	Thesis
author	Mirza, Maisa Tasnim
author_sort	Mirza, Maisa Tasnim
title	Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
title_short	Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
title_full	Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
title_fullStr	Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
title_full_unstemmed	Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
title_sort	tamoxifen: the ideal post operative hormonal therapy to demote ductal carcinoma in situ
publisher	Brac University
publishDate	2023
url	http://hdl.handle.net/10361/18147
work_keys_str_mv	AT mirzamaisatasnim tamoxifentheidealpostoperativehormonaltherapytodemoteductalcarcinomainsitu
_version_	1814309793689501696

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ

Similar Items